相关实验视频

Updated: Jun 16, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

针对肝细胞癌的向免疫组合的现状和未来

Liyuan Hao^1,2, Shenghao Li^1,2, Fanghang Ye^1,2

¹Clinical Medical College, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.

Frontiers in immunology

|August 20, 2024

概括

肝细胞癌 (HCC) 治疗方法正在发展. 将免疫检查点抑制剂 (ICI) 与向治疗相结合,对晚期肝癌具有前途,为其免疫抑制瘤微环境提供了新的希望.

科学领域:

肝病学和瘤学肝病学和瘤学
免疫疗法研究免疫疗法研究

背景情况:

肝细胞癌 (HCC) 是全球癌症死亡的主要原因,目前的治疗由于瘤微环境的免疫抑制性质而面临挑战.
在HCC中,免疫逃逸是由免疫检查点分子 (PD-1,PD-L1,CTLA-4) 和免疫抑制性细胞因子驱动的,需要新的治疗策略.

研究的目的:

审查最近在结合免疫检查点抑制剂 (ICI) 与针对高级或不可切除的肝细胞癌 (aHCC/uHCC) 的向药物的进展.
探索向免疫组合疗法在肝癌治疗中的有效性和未来前景.

主要方法:

在过去五年内发表的研究的文献综述.
使用的关键词:"肝细胞癌"",免疫检查点抑制剂"",向治疗"",组合治疗"和"免疫治疗".

主要成果:

免疫疗法,特别是免疫检查点抑制剂 (ICI),单独或与其他药物结合,在治疗肝癌方面显著有前途.
涉及ICI和向药物 (向免疫组合) 的组合疗法正在成为高级HCC的关键策略.

结论:

针对性免疫组合疗法代表了治疗高级和不可切除的HCC的前沿前沿.
对这些组合的持续研究对于改善肝癌患者的治疗结果至关重要.

关键词:

在 CTLA-4 中.在HCC中,HCC是HCC.在ICIS中,我们可以看到ICIS.这是一种抗PD-1药物.这是一种抗PD-L1的药物.有针对性的免疫组合.

更多相关视频

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...